QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
OTCMKTS:INNV

InnovAge - INNV Price Target & Analyst Ratings

$7.50
-0.11 (-1.45%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$7.31
▼
$7.76
50-Day Range
$6.48
▼
$7.69
52-Week Range
$3.39
▼
$8.03
Volume
114,096 shs
Average Volume
49,266 shs
Market Capitalization
$1.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.98

InnovAge Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$5.98
-20.27% Downside
High Prediction$8.00
Average Prediction$5.98
Low Prediction$3.90
TypeCurrent
2/7/22 to 2/7/23		1 Month Ago
1/8/22 to 1/8/23		3 Months Ago
11/9/21 to 11/9/22		1 Year Ago
2/7/21 to 2/7/22
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
7 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.98$5.98$5.58$10.93
Predicted Upside-20.27% Downside3.68% Upside-0.61% Downside21.41% Upside
Get InnovAge Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter.

INNV Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

INNV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

InnovAge Stock vs. The Competition

TypeInnovAgeMedical CompaniesS&P 500
Consensus Rating Score
1.75
2.64
2.47
Consensus RatingHoldBuyHold
Predicted Upside-20.27% Downside1,308.55% Upside8.49% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/23/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetNeutral$6.00 ➝ $8.00+19.05%
11/16/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost Target$5.00 ➝ $8.00+10.96%
9/15/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetEqual Weight$6.00 ➝ $5.00+1.21%
5/16/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOutperform ➝ Neutral$6.00 ➝ $5.00-2.53%
5/11/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower Target$5.00 ➝ $3.90-13.91%
12/17/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageNeutral$10.00+29.37%
9/22/2021William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating		DowngradeOutperform ➝ Market Perform
9/9/2021Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform$17.00+11.62%
(Data available from 2/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












INNV Price Target - Frequently Asked Questions

What is InnovAge's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for InnovAge stock is Hold based on the current 1 sell rating and 3 hold ratings for INNV. The average twelve-month price prediction for InnovAge is $5.98 with a high price target of $8.00 and a low price target of $3.90. Learn more on INNV's analyst rating history.

Do Wall Street analysts like InnovAge more than its competitors?

Analysts like InnovAge less than other Medical companies. The consensus rating for InnovAge is Hold while the average consensus rating for medical companies is Buy. Learn more on how INNV compares to other companies.

Does InnovAge's stock price have much upside?

According to analysts, InnovAge's stock has a predicted upside of 3.68% based on their 12-month price targets.

What analysts cover InnovAge?

InnovAge has been rated by Citigroup, and The Goldman Sachs Group in the past 90 days.


Stock Ratings Reports and Tools

Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
Ratings for Popular Stocks:
This page (OTCMKTS:INNV) was last updated on 2/7/2023 by MarketBeat.com Staff